Zurueck zur Suche

Reporte zur Charge P39N2

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 4 TX 4 IN 2 SC 2 NC 2 AZ 1 MT 1 ID 1 CO 1

VAERS 2604177

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

moderat
Staat
IN
Alter
56,0
Geschlecht
F
Eingang
27.03.2023
Impfdatum
20.03.2023
Beginn
21.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Dizziness Oral mucosal eruption Palpitations Rash Rash vesicular

Symptomtext

GOT UP AROUND 3 AM, BEGAN TO FEEL AS THOUGH HER HEART WAS POUNDING. STATES SHE FELT DIZZY AND WEAK, HAD TO CRAWL BACK TO HER BEDROOM SO SHE DIDN'T FALL. STATES SHE NOTICED A BLISTERED RASH IN THE OCRNER OF HER MOUTH AND ON HER CHIN. DAUGHTER CALLED ER. ER TOLD DAUGHTER TO "WATCH HER". THE FOLLOWING MORNING PATIENT FELT WELL ENOUGH TO WORK. STATES SHE LEFT V/M AT DR'S OFFICE. DR.'S OFFICE RETURNED CALL, LEAVING V/M TELLING HER THEY WOULD "NOTE IT IN YOUR CHART".

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
HYPOTHYROIDISM
Andere Medikamente
SYNTHROID CALCIUM B12 SUPPLEMENT VITAMIN D SUPPLEMENT MULTIVITAMIN
Allergien
MORPHINE
Vorherige Impfungen
-

VAERS 2528397

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge p39n2

moderat
Staat
FL
Alter
54,0
Geschlecht
F
Eingang
10.12.2022
Impfdatum
26.11.2022
Beginn
26.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Condition aggravated Dizziness

Symptomtext

Patient had dizziness prior to vaccine which got worse after receiving vaccine. Has not tried any treatments. Dizziness is improving.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
thyroid, hx breast cancer, high cholesterol, anxiety
Andere Medikamente
alprazolam, synthroid, livalo, sumatriptan
Allergien
nka
Vorherige Impfungen
-

VAERS 2521060

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

moderat
Staat
SC
Alter
61,0
Geschlecht
F
Eingang
01.12.2022
Impfdatum
15.11.2022
Beginn
25.11.2022
Tage bis Beginn
10,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Condition aggravated Varicella

Symptomtext

PATIENT STATED THAT SHE BROKE OUT WITH CHICKENPOX. HER PHYSICIAN CONFIRMED THAT SHE HAD A REACTIVATION (ORIGINAL CHICKENPOX OUTBREAK IN HER 20'S).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
VICODIN AND ATORVASTATIN
Vorherige Impfungen
-

VAERS 2472883

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge p39n2

moderat
Staat
TX
Alter
56,0
Geschlecht
F
Eingang
09.10.2022
Impfdatum
08.10.2022
Beginn
09.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest pain Herpes zoster Palpitations Vaccination site pain Vaccination site swelling

Symptomtext

pt had palpitations ,chest pain ,swelling and pain from side on plank from armpit on both vacccine site ,dr suspected from vaccine mostly shingles

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
went to emergency
Aktuelle Erkrankungen
back pain ,nueropathy
Vorgeschichte
neuropathy ,crohns disease
Andere Medikamente
nortriptylline ,trazodone ,omeprazole ,pregablin
Allergien
codiene
Vorherige Impfungen
-

VAERS 2603649

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

mild
Staat
TX
Alter
58,0
Geschlecht
F
Eingang
24.03.2023
Impfdatum
19.01.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain

Symptomtext

Sharp shooting burning pain from left deltoid to bottom of neck; Sharp shooting burning pain from left deltoid to bottom of neck; This non-serious case was reported by a nurse via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) (batch number P39N2, expiry date 25-SEP-2023) for prophylaxis. On 19-JAN-2023, the patient received Shingrix (left deltoid). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Sharp shooting burning pain from left deltoid to bottom of neck) and pain burning (Verbatim: Sharp shooting burning pain from left deltoid to bottom of neck). The outcome of the injection site pain and pain burning were not recovered/not resolved. It was unknown if the reporter considered the injection site pain and pain burning to be related to Shingrix. It was unknown if the company considered the injection site pain and pain burning to be related to Shingrix. Additional Information: GSK receipt date: 10-Mar-2023 The nurse practitioner called to inquired that any information available on what patient was experiencing. The reporter reported that a patient received the first dose of Shingrix back and experienced a sharp shooting burning pain from left deltoid to bottom of neck. The reporter reported another batch number as 752BN and expiry date 20th May 2024. Then the patient came back for the second dose on 19th January 2023 and was still experiencing the adverse events from the first dose that had never gone away. The reporter consented to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2536576

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

mild
Staat
-
Alter
51,0
Geschlecht
F
Eingang
19.12.2022
Impfdatum
02.12.2022
Beginn
05.12.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Breast pain Breast swelling Muscle discomfort Oedema peripheral

Symptomtext

Patient states that she experience soreness and swelling under her right arm extending to her breast. She described that it felt almost like she pulled a muscle.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2508958

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39n2

mild
Staat
FL
Alter
53,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
22.10.2022
Beginn
24.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Erythema Headache Pruritus Pyrexia Sleep disorder

Symptomtext

My whole body turned red and itchy, I had a fever, I had a severe headache, and I couldn't sleep at night because of the chills.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Take Tylenol for Headache and Fever. Take Methylprednisolone Tablets USP 4 mg for 6 days.
Aktuelle Erkrankungen
Non
Vorgeschichte
Good
Andere Medikamente
Vitamin
Allergien
Non
Vorherige Impfungen
-

VAERS 2499288

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge p39n2

mild
Staat
AZ
Alter
53,0
Geschlecht
F
Eingang
04.11.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Dizziness Feeling drunk Headache

Symptomtext

At around 7pm on 11/03/2022 patient states she had a severe headache which has subsided but still present. Is now experiencing dizziness. States her equilibrium is off and feels as if she was drunk. Headache is still present but not as severe as the night prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
obesity
Andere Medikamente
trazodone, duloxetine
Allergien
penicillin, clindamycin, sulfa, tramadol
Vorherige Impfungen
-

VAERS 2490990

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

mild
Staat
NC
Alter
51,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Pain in extremity

Symptomtext

Patient was given her 2nd dose of shingrix to her (R) deltoid. After a minute of administered, her (R) swells up on where the site was given. Provider were in presence to observe and ordered Solu-Medrol for patient. Patient stated the arm just hurts and nothing more. No other side effects were known. After 15 mins of waiting, swelling went down.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Plantar fasciitis
Vorgeschichte
HTN, Type 2 DM, Iron deficiency
Andere Medikamente
n/a
Allergien
Imdur
Vorherige Impfungen
-

VAERS 2475800

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39n2

mild
Staat
TX
Alter
57,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
10.10.2022
Beginn
11.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Feeling hot Headache Pain

Symptomtext

Patient states that last night she began to feel body aches and a severe headache that radiates down the neck. Patient states feeling all hot inside but does not have fever.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
none listed
Andere Medikamente
patient did not list
Allergien
no know allergy
Vorherige Impfungen
previous shingles vaccine 8/10/2022 she had a headache

VAERS 2715461

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
FL
Alter
54,0
Geschlecht
F
Eingang
18.11.2023
Impfdatum
18.01.2023
Beginn
18.01.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Patient doesn't have adverse reactions. However, this is the 3rd dose of the Shingrix. Patient received this dose by mistake. Shingrix should have only been 2 doses.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2661491

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
SC
Alter
63,0
Geschlecht
F
Eingang
26.07.2023
Impfdatum
09.10.2022
Beginn
10.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling

Symptomtext

Arm was swollen

Weitere VAERSDATA-Felder
Praegender Schweregrund
Peripheral swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Glaucoma, Iron deficiency, Hypertension, Peptic Ulcer, Angina Pectoris
Andere Medikamente
Meloxicam 15 mg, Amlodipine 10 mg, Atenolol 50 mg, Benazepril 40 mg, Diclofenac 1% gel, Metformin 1000 mg, Pravastatin 80 mg, Triamterene-HCTZ 75/50 mg, Allopurinol 300 mg, Colchicine 0.6 mg, Pioglitazone 30 mg
Allergien
None
Vorherige Impfungen
-

VAERS 2579621

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
FL
Alter
63,0
Geschlecht
F
Eingang
10.02.2023
Impfdatum
21.12.2022
Beginn
10.02.2023
Tage bis Beginn
51,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

Patient did not have any adverse event, but this was the 3rd Shingrix vaccine patient received. She should not have received this vaccine. She should have received another vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
-
Andere Medikamente
-
Allergien
NA
Vorherige Impfungen
-

VAERS 2538591

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
TX
Alter
72,0
Geschlecht
F
Eingang
21.12.2022
Impfdatum
09.12.2022
Beginn
09.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

2nd dose given less than a month apart; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number P39N2, expiry date 25th September 2023) for prophylaxis. Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX). On 9th December 2022, the patient received the 2nd dose of Shingrix. On 9th December 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The patient was immunocompetent. The reporter consented to follow-up by email. Additional supportive information: The patient received second dose of Shingrix earlier than recommended interval, which led to shortening of vaccine schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2518662

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
MT
Alter
87,0
Geschlecht
M
Eingang
29.11.2022
Impfdatum
07.11.2022
Beginn
07.11.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error

Symptomtext

Administration error, 3rd dose given of a 2 dose series.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Penicillin Allergy
Vorherige Impfungen
-

VAERS 2513524

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
NC
Alter
55,0
Geschlecht
M
Eingang
22.11.2022
Impfdatum
11.11.2022
Beginn
11.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation issue

Symptomtext

Administered the adjuvant only; Administered the adjuvant only; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old male patient who received Herpes zoster (Shingrix) (batch number P39N2, expiry date 25th September 2023) for prophylaxis. On 11th November 2022, the patient received Shingrix. On 11th November 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK receipt date: 11-Nov-2022 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient was administered the Shingrix vaccine adjuvant without the active component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2512584

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
ID
Alter
18,0
Geschlecht
F
Eingang
20.11.2022
Impfdatum
20.11.2022
Beginn
20.11.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Patient was with her father. She was receiving Pfizer bivalent vaccine and fluarix and her father was receiving Shingrix. She was in given Shingrix by the pharmacy intern at 4:20 pm. She was monitored for signs/ symptoms for 20 minutes without incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2507845

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge P39N2

gering
Staat
IN
Alter
59,0
Geschlecht
F
Eingang
15.11.2022
Impfdatum
04.11.2022
Beginn
04.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Exposure via skin contact Incorrect dose administered

Symptomtext

4-5 droplets came out from syringe; Vaccine maybe touched patient?s arm; Vaccine maybe touched patient?s arm; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number P39N2, expiry date 25th September 2023) for prophylaxis. On 4th November 2022, the patient received the 2nd dose of Shingrix. On 4th November 2022, unknown after receiving Shingrix, the patient experienced incomplete dose administered, exposure via skin contact and accidental exposure while administering drug. On an unknown date, the outcome of the incomplete dose administered, exposure via skin contact and accidental exposure while administering drug were unknown. Additional Information: GSK Receipt Date: 04-NOV-2022 Reporter's comment: Pharmacist reported that while she was administering a Shingrix vaccine in the right arm to a patient, 4-5 droplets of the vaccine came out around the base of the needle where it attached to the syringe while the syringe with the reconstituted vaccine was in the patient's arm. The pharmacist said 4-5 droplets of the reconstituted Shingrix vaccine when it came out of the syringe on the patient's pant and maybe the patient's arms. The reporter did not consent to follow-up. Additional Supportive Information: The 4-5 droplets of the reconstituted Shingrix vaccine when it came out of the syringe on the patient's pant and maybe the patient's arms, which led incomplete dose administered, exposure via skin contact and accidental exposure while administering drug. The case US2022161294 was identified as duplicate of this case. The case US2022161294 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient. The case is linked to the case US2022AMR162313, reported by the same reporter.; Sender's Comments: US-GSK-US2022AMR162313:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2497867

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge p39n2

gering
Staat
CO
Alter
64,0
Geschlecht
M
Eingang
03.11.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

3rd dose administered. No current ADRs. Patient remains in good health

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
gout
Andere Medikamente
Allopurinol
Allergien
NKA
Vorherige Impfungen
-